Associated Papers
Tumorigenic p53 mutants undergo common structural disruptions including conversion to α-sheet structure.
Bromley D et al.
Protein Science : a Publication of the Protein Society, 2020
In silico approaches to identify the potential inhibitors of glutamate carboxypeptidase II (GCPII) for neuroprotection.
Naushad SM et al.
Journal of Theoretical Biology, 2016
Clinical utility of genetic variants of glutamate carboxypeptidase II in predicting breast cancer and prostate cancer risk.
Naushad SM et al.
Cancer Genetics, 2015
Association of glutamate carboxypeptidase II (GCPII) haplotypes with breast and prostate cancer risk.
Divyya S et al.
Gene, 2013
Glutamate carboxypeptidase II (GCPII) genetic variants as determinants of hyperhomocysteinemia: implications in stroke susceptibility.
Divyya S et al.
Indian Journal of Biochemistry & Biophysics, 2012
Select a paper to view details